Indoco Remedies Limited (INDOCO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Indoco Remedies Limited (INDOCO) has a cash flow conversion efficiency ratio of 0.162x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.58 Billion ≈ $17.06 Million USD) by net assets (Rs9.74 Billion ≈ $105.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Indoco Remedies Limited (INDOCO) balance sheet quality index to measure how much of total assets are equity-financed.
Indoco Remedies Limited - Cash Flow Conversion Efficiency Trend (2004–2026)
This chart illustrates how Indoco Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Indoco Remedies Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Indoco Remedies Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Indoco Remedies Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Arad Investment & Industrial Development Ltd
TA:ARAD
|
0.124x |
|
Pennar Industries Limited
NSE:PENIND
|
0.108x |
|
Fossil Group Inc
NASDAQ:FOSL
|
-0.262x |
|
Baazar Style Retail Limited
NSE:STYLEBAAZA
|
0.240x |
|
Sizzle Acquisition Corp. II - Class A ordinary shares
NASDAQ:SZZL
|
0.000x |
|
Live Oak Acquisition Corp. V Class A Ordinary Shares
NASDAQ:LOKV
|
-0.003x |
|
Jasuindo Tiga Perkasa Tbk
JK:JTPE
|
-0.046x |
|
Shanghai Lisheng Racing Co Ltd
SHE:002858
|
0.016x |
Annual Cash Flow Conversion Efficiency for Indoco Remedies Limited (2004–2026)
The table below shows the annual cash flow conversion efficiency of Indoco Remedies Limited from 2004 to 2026. For the full company profile with market capitalisation and key ratios, see Indoco Remedies Limited (INDOCO) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs9.32 Billion ≈ $100.81 Million |
Rs324.30 Million ≈ $3.51 Million |
0.035x | +27.04% |
| 2025-03-31 | Rs10.18 Billion ≈ $110.13 Million |
Rs278.90 Million ≈ $3.02 Million |
0.027x | -80.43% |
| 2024-03-31 | Rs11.10 Billion ≈ $120.10 Million |
Rs1.55 Billion ≈ $16.80 Million |
0.140x | -19.54% |
| 2023-03-31 | Rs10.28 Billion ≈ $111.20 Million |
Rs1.79 Billion ≈ $19.34 Million |
0.174x | -9.50% |
| 2022-03-31 | Rs9.05 Billion ≈ $97.83 Million |
Rs1.74 Billion ≈ $18.80 Million |
0.192x | +79.71% |
| 2021-03-31 | Rs7.69 Billion ≈ $83.16 Million |
Rs822.22 Million ≈ $8.89 Million |
0.107x | -40.85% |
| 2020-03-31 | Rs6.80 Billion ≈ $73.49 Million |
Rs1.23 Billion ≈ $13.29 Million |
0.181x | -9.61% |
| 2019-03-31 | Rs6.61 Billion ≈ $71.44 Million |
Rs1.32 Billion ≈ $14.29 Million |
0.200x | +10.00% |
| 2018-03-31 | Rs6.75 Billion ≈ $73.00 Million |
Rs1.23 Billion ≈ $13.27 Million |
0.182x | +33.64% |
| 2017-03-31 | Rs6.52 Billion ≈ $70.46 Million |
Rs886.40 Million ≈ $9.59 Million |
0.136x | -29.86% |
| 2016-03-31 | Rs5.84 Billion ≈ $63.19 Million |
Rs1.13 Billion ≈ $12.26 Million |
0.194x | -8.10% |
| 2015-03-31 | Rs5.19 Billion ≈ $56.11 Million |
Rs1.09 Billion ≈ $11.84 Million |
0.211x | -2.30% |
| 2014-03-31 | Rs4.57 Billion ≈ $49.47 Million |
Rs988.09 Million ≈ $10.69 Million |
0.216x | +29.87% |
| 2013-03-31 | Rs4.14 Billion ≈ $44.78 Million |
Rs688.69 Million ≈ $7.45 Million |
0.166x | +8.53% |
| 2012-03-31 | Rs3.85 Billion ≈ $41.61 Million |
Rs589.71 Million ≈ $6.38 Million |
0.153x | +27.38% |
| 2011-03-31 | Rs3.50 Billion ≈ $37.87 Million |
Rs421.36 Million ≈ $4.56 Million |
0.120x | -21.91% |
| 2010-03-31 | Rs3.11 Billion ≈ $33.58 Million |
Rs478.40 Million ≈ $5.17 Million |
0.154x | +13.60% |
| 2009-03-31 | Rs2.78 Billion ≈ $30.11 Million |
Rs377.64 Million ≈ $4.08 Million |
0.136x | +30.76% |
| 2008-03-31 | Rs2.54 Billion ≈ $27.50 Million |
Rs263.71 Million ≈ $2.85 Million |
0.104x | +185.15% |
| 2007-03-31 | Rs2.33 Billion ≈ $25.20 Million |
Rs84.76 Million ≈ $916.63K |
0.036x | -80.49% |
| 2006-03-31 | Rs1.98 Billion ≈ $21.45 Million |
Rs369.86 Million ≈ $4.00 Million |
0.186x | +438.09% |
| 2005-03-31 | Rs1.75 Billion ≈ $18.96 Million |
Rs60.74 Million ≈ $656.92K |
0.035x | -81.85% |
| 2004-03-31 | Rs880.11 Million ≈ $9.52 Million |
Rs168.02 Million ≈ $1.82 Million |
0.191x | -- |
About Indoco Remedies Limited
Indoco Remedies Limited manufactures and markets formulations and active pharmaceutical ingredients in India and internationally. It offers products for gastrointestinal, anti-infectives, respiratory, stomatological, vitamins/minerals/nutrients, urological, ophthal/ontological, dermatology, pain/analgesic, cardiac, anti-diabetic, and gynaecological therapeutic areas. The company also provides bra… Read more